本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Revolution Medicines, Inc.

40.72
+0.08000.20%
盘后40.720.00000.00%19:34 EDT
成交量:173.40万
成交额:7,132.99万
市值:75.70亿
市盈率:-11.38
高:41.80
开:41.26
低:40.70
收:40.64
数据加载中...
2022/02/28

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/28

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/04

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/01/11

重要事件披露

8-K - Current report
2021/11/10

重要事件披露

8-K - Current report
2021/11/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/11/04

重要事件披露

8-K - Current report
2021/08/11

重要事件披露

8-K - Current report
2021/08/11

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/06/23

重要事件披露

8-K - Current report
2021/05/19

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/05/17

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/05/10

重要事件披露

8-K - Current report
2021/05/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/04/30

重要事件披露

8-K - Current report